AeroVironment lands first directed-energy production contract, but stock decline persists amid execution concerns

What happened

AeroVironment secured what it calls the first U.S. military production contract for directed-energy weapons, with the CEO asserting a $10-per-shot cost advantage over $150,000 drones. Despite this milestone, the stock has fallen nearly 41% over the past year, indicating that investors remain focused on the company's unresolved execution challenges. The DeepValue report highlights persistent internal control weaknesses, a $240.7 million goodwill impairment in the Space unit, and negative EBITDA in the Space, Cyber and Directed Energy (SCDE) segment, which casts doubt on the profitability of the new contract. While the directed-energy award adds a growth vector, it does not address the fundamental concerns of margin compression (Q4 FY26 gross margin fell to 32% from 36%) and the need to prove backlog conversion. The market's tepid reaction suggests that until the company demonstrates improved financial controls and segment profitability, even positive technological milestones may fail to reverse the stock's decline.

Implication

The contract provides incremental validation of AeroVironment's directed-energy technology, but its financial impact is unclear and likely insufficient to offset the company's current challenges. Given the SCDE segment's negative EBITDA and history of program cancellations, investors should treat this as a potential turning point that requires multiple quarters of profitable execution to confirm. The stock's continued decline despite positive news underscores that the market is pricing in execution risk, and contrarian buying now carries substantial downside if control weaknesses persist. Key catalysts to monitor include the next 10-Q/10-K for evidence of ICFR remediation, follow-on orders on the directed-energy contract, and any update on SCDE profitability. Until those signals materialize, maintaining the existing WAIT rating with an attractive entry near $145 and trim above $190 remains appropriate, as the risk-reward is not compelling at current levels.

Thesis delta

The new directed-energy production contract incrementally strengthens the demand narrative and supports the company's strategic pivot to directed energy, but it does not alter the core concerns around internal controls, margin quality, and SCDE profitability. The WAIT rating remains appropriate, with no change to the attractive entry or trim levels at this time.